文献速递细胞病理与分子病理

国际浆膜腔积液细胞病理报告系统在 pericardial fluid 中的应用:不确定诊断根因分析、细胞组织学相关性与恶性风险评估

Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
PubMed 文献 · Cancer Cytopathol · 2023-03-27

本研究回顾性分析耶鲁医学院2017-2020年465例心包积液细胞学病例,按ISRSFC五分类重新分类并计算恶性风险(ROM)及诊断性能。结果显示ROM在ND、NFM、AUS、SFM、MAL分别为0%、1.3%、20%、100%、100%,诊断敏感性87%、特异性100%、准确率98.8%,表明ISRSFC对心包积液报告和风险评估高度有用。

要点

  • ISRSFC五分类可用于心包积液,SFM和MAL的ROM均为100%。
  • AUS的ROM为20%,需结合临床进一步评估。
  • 诊断特异性与PPV均为100%,准确率98.8%。

核心结论

  • ISRSFC是心包积液报告和风险评估的高度有用系统,具有高敏感性、特异性、PPV、NPV和诊断准确率。

主要发现

  • 465例分布:ND 19例(4.1%)、NFM 332例(71.4%)、AUS 21例(4.5%)、SFM 11例(2.4%)、MAL 82例(17.6%)。
  • 确认性随访可获得例数:ND 16例(66.7%)、NFM 299例(90%)、AUS 15例(71%)、SFM 5例(45.5%)、MAL 30例(36.6%)。
  • ROM:ND 0%、NFM 1.3%(4/332)、AUS 20%(3/15)、SFM 100%(5/5)、MAL 100%(27/27)。
  • 诊断性能:敏感性87%(27/31)、特异性100%(292/292)、PPV 100%(27/27)、NPV 98.6%(292/296)、准确率98.8%(319/323)。

关键数值与推荐

  • ISRSFC五分类:ND、NFM、AUS、SFM、MAL。
  • ROM在SFM和MAL均为100%,AUS为20%,NFM为1.3%,ND为0%。

临床怎么用

  • 应用ISRSFC对心包积液进行标准化分类报告,有助于风险评估和临床决策。
  • 对AUS病例应结合临床和影像学进一步评估,因ROM为20%。
  • SFM和MAL病例的ROM为100%,应积极临床干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigates the utility of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in the categorization of pericardial fluid and assesses the diagnostic performance and risk of malignancy (ROM) for each of the diagnostic categories. METHODS: All pericardial fluid cases at the Yale School of Medicine between January 1, 2017, and December 31, 2020, were reviewed. The diagnoses were reclassified into five categories according to the ISRSFC: nondiagnostic (ND), negative for malignancy (NFM), atypia of uncertain significance (AUS), suspicious for malignancy (SFM), and malignant (MAL). ROM and performance parameters of each category were calculated. RESULTS: After reclassification, the distribution of 465 pericardial fluid cases in each category was as follows: ND, 19 (4.1%); NFM, 332 (71.4%); AUS, 21 (4.5%); SFM, 11 (2.4%); and MAL, 82 (17.6%). Confirmatory follow-ups were available for 16 ND (66.7%), 299 NFM (90%), 15 AUS (71%), 5 SFM (45.5%), and 30 MAL cases (36.6%). The ROM was 0% for ND, 1.3% for NFM (4 of 332), 20% for AUS (3 of 15), and 100% for both SFM (5 of 5) and MAL (27 of 27). The diagnostic performance was as follows: sensitivity, 87% (27 of 31); specificity, 100% (292 of 292); positive predictive value (PPV), 100% (27 of 27); negative predictive value (NPV), 98.6% (292 of 296); and diagnostic accuracy, 98.8% (319 of 323). CONCLUSIONS: The ISRSFC is a highly useful system for the reporting of pericardial fluid and risk assessment, given that it offers high sensitivity, specificity, PPV, NPV, and diagnostic accuracy. The application of this system may help to better categorize pericardial fluid and facilitate the standardization of cytopathology reporting.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wang M, Sun T, Jiao J, et al. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk. Cancer Cytopathol. 2023. PMID: 36973963. doi:10.1002/cncy.22696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。